|
G |
Adm |
adrenomedullin |
increases expression |
ISO |
Pamidronate results in increased expression of ADM mRNA |
CTD |
PMID:38447685 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases expression |
ISO |
pamidronate results in increased expression of ALPL protein |
CTD |
PMID:11683535 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
B2m |
beta-2 microglobulin |
decreases expression |
ISO |
pamidronate results in decreased expression of B2M protein |
CTD |
PMID:11683535 |
|
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
pamidronate results in decreased expression of BCL2 protein |
CTD |
PMID:10780527 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
increases expression |
ISO |
pamidronate results in increased expression of BGLAP protein |
CTD |
PMID:11683535 |
|
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Bik |
BCL2-interacting killer |
increases response to substance |
ISO |
BIK protein results in increased susceptibility to pamidronate |
CTD |
PMID:16007125 |
|
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases cleavage |
ISO |
pamidronate results in increased cleavage of and results in increased activity of CASP3 protein pamidronate results in increased cleavage of CASP3 protein |
CTD |
PMID:15346059 PMID:16298452 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases cleavage |
ISO |
pamidronate results in increased cleavage of CASP9 protein |
CTD |
PMID:16298452 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression |
ISO |
pamidronate results in decreased expression of COL1A1 mRNA; pamidronate results in decreased expression of COL1A1 protein |
CTD |
PMID:19597852 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Crp |
C-reactive protein |
decreases expression increases expression |
ISO |
pamidronate results in decreased expression of CRP protein pamidronate results in increased expression of CRP protein |
CTD |
PMID:9351880 PMID:11683535 |
|
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases expression |
ISO |
Pamidronate results in increased expression of CXCR4 mRNA |
CTD |
PMID:38447685 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
Pamidronate results in increased expression of DUSP1 mRNA |
CTD |
PMID:38447685 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
[Arsenic Trioxide co-treated with Pamidronate] promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein]; Pamidronate promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein] |
CTD |
PMID:32337366 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
[Arsenic Trioxide co-treated with Pamidronate] promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein]; Pamidronate promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein] |
CTD |
PMID:32337366 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Fdps |
farnesyl diphosphate synthase |
decreases activity |
ISO EXP |
pamidronate results in decreased activity of FDPS protein |
CTD |
PMID:11160603 PMID:18325729 |
|
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
|
|
G |
Fgf23 |
fibroblast growth factor 23 |
decreases expression |
ISO |
pamidronate results in decreased expression of FGF23 protein |
CTD |
PMID:15838626 |
|
NCBI chr 4:159,914,267...159,923,821
Ensembl chr 4:159,914,272...159,923,821
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO |
[Pamidronate results in increased susceptibility to Acetylmuramyl-Alanyl-Isoglutamine] which results in increased secretion of IL18 protein |
CTD |
PMID:21282739 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
increases secretion multiple interactions |
ISO |
Pamidronate results in increased secretion of IL1B protein [Pamidronate co-treated with Acetylmuramyl-Alanyl-Isoglutamine] results in increased secretion of IL1B protein; [Pamidronate co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein; geraniol inhibits the reaction [[Pamidronate co-treated with Acetylmuramyl-Alanyl-Isoglutamine] results in increased secretion of IL1B protein]; geraniol inhibits the reaction [[Pamidronate co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein]; Pamidronate promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL1B protein] |
CTD |
PMID:21282739 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
decreases expression increases expression |
ISO |
pamidronate results in decreased expression of IL6 protein pamidronate results in increased expression of IL6 protein |
CTD |
PMID:9351880 PMID:11683535 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Klhdc2 |
kelch domain containing 2 |
decreases expression |
ISO |
Pamidronate results in decreased expression of KLHDC2 mRNA |
CTD |
PMID:38447685 |
|
NCBI chr 6:87,777,183...87,791,609
Ensembl chr 6:87,777,183...87,804,187
|
|
G |
Ldha |
lactate dehydrogenase A |
increases expression |
ISO |
Pamidronate results in increased expression of LDHA mRNA |
CTD |
PMID:38447685 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
Pamidronate results in increased expression of MAFF mRNA |
CTD |
PMID:38447685 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases expression |
ISO |
pamidronate results in decreased expression of MAPK1 protein modified form |
CTD |
PMID:16298452 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Msmo1 |
methylsterol monooxygenase 1 |
increases expression |
ISO |
Pamidronate results in increased expression of MSMO1 mRNA |
CTD |
PMID:38447685 |
|
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage multiple interactions |
ISO |
pamidronate results in increased cleavage of PARP1 protein [pamidronate co-treated with ultra-high molecular weight polyethylene] results in increased cleavage of PARP1 protein |
CTD |
PMID:10780527 PMID:12507583 PMID:15346059 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pon1 |
paraoxonase 1 |
decreases activity multiple interactions |
EXP |
pamidronate results in decreased activity of PON1 protein [pamidronate results in decreased activity of PON1 protein] which results in decreased metabolism of homocysteine thiolactone; [pamidronate results in decreased activity of PON1 protein] which results in decreased metabolism of Paraoxon; [pamidronate results in decreased activity of PON1 protein] which results in decreased metabolism of phenyl acetate |
CTD |
PMID:27387541 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
increases expression |
ISO |
Pamidronate results in increased expression of PPP1R15A mRNA |
CTD |
PMID:38447685 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Pamidronate results in decreased expression of and results in decreased activity of PTPN1 protein]]; Acetylcysteine inhibits the reaction [Pamidronate promotes the reaction [Arsenic Trioxide results in decreased expression of and results in decreased activity of PTPN1 protein]]; Acetylcysteine inhibits the reaction [Pamidronate results in decreased expression of and results in decreased activity of PTPN1 protein]; Arsenic Trioxide promotes the reaction [Pamidronate results in decreased expression of and results in decreased activity of PTPN1 protein]; Pamidronate promotes the reaction [Arsenic Trioxide results in decreased expression of and results in decreased activity of PTPN1 protein]; Pamidronate results in decreased expression of and results in decreased activity of PTPN1 protein |
CTD |
PMID:32337366 |
|
NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504
|
|
G |
Rac1 |
Rac family small GTPase 1 |
multiple interactions |
ISO |
pamidronate increases expression of RAC1 mRNA in cholangiocarcinoma cells, pamidronate decreases expression of RAC1 protein in cholangiocarcinoma cells |
RGD |
PMID:31611937 |
RGD:153345545 |
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Rap1a |
RAP1A, member of RAS oncogene family |
decreases prenylation |
ISO |
pamidronate results in decreased prenylation of RAP1A protein |
CTD |
PMID:11595616 |
|
NCBI chr 2:193,208,631...193,286,513
Ensembl chr 2:193,208,635...193,286,501
|
|
G |
Rhoa |
ras homolog family member A |
decreases expression |
ISO |
pamidronate results in decreased expression of RHOA protein modified form |
CTD |
PMID:16298452 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
decreases expression |
ISO |
pamidronate results in decreased expression of ROCK1 protein |
CTD |
PMID:16298452 |
|
NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571
|
|
G |
Sertad1 |
SERTA domain containing 1 |
increases expression |
ISO |
Pamidronate results in increased expression of SERTAD1 mRNA |
CTD |
PMID:38447685 |
|
NCBI chr 1:82,775,692...82,778,961
Ensembl chr 1:82,775,252...82,779,091
|
|
G |
Tnf |
tumor necrosis factor |
increases expression multiple interactions |
ISO |
pamidronate results in increased expression of TNF protein pamidronate inhibits the reaction [ultra-high molecular weight polyethylene results in increased secretion of TNF protein] |
CTD |
PMID:9351880 PMID:12507583 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11B |
multiple interactions increases expression |
ISO |
pamidronate inhibits the reaction [Dexamethasone results in decreased expression of TNFRSF11B mRNA]; pamidronate inhibits the reaction [Dexamethasone results in decreased expression of TNFRSF11B protein] pamidronate results in increased expression of TNFRSF11B mRNA; pamidronate results in increased expression of TNFRSF11B protein |
CTD |
PMID:11855844 |
|
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
|
|